Patents by Inventor Mi Zeng

Mi Zeng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240228490
    Abstract: A heterocyclic derivative inhibitor and a preparation method therefor and an application thereof. Specifically, the present invention relates to a compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition comprising said compound, and an application of same as an inhibitor for treatment of cancers, wherein substituents in general formula (I) are as defined in the description.
    Type: Application
    Filed: April 22, 2022
    Publication date: July 11, 2024
    Inventors: Peng Gao, Mi Zeng, Shaobao Wang, Wensheng Yu
  • Publication number: 20230105212
    Abstract: A biphenyl derivative inhibitor represented by general formula (Ib) and use in the preparation of medicaments for treating cancer, infectious diseases, and autoimmune diseases.
    Type: Application
    Filed: December 30, 2020
    Publication date: April 6, 2023
    Inventors: Mi ZENG, Peng GAO, Wenjie QI, Jian LI, Yu CHENG, Ting WANG, Rudi BAO
  • Publication number: 20230043863
    Abstract: The present invention relates to heteroaromatic derivatives for use as a regulator, a preparation method therefor and a use thereof. In particular, disclosed are compounds represented by general formula (I), preparation methods therefor, pharmaceutical compositions comprising said compounds, and a use thereof as Janus kinase inhibitors in treating inflammatory diseases and tumor-related diseases.
    Type: Application
    Filed: November 29, 2019
    Publication date: February 9, 2023
    Inventors: Mi ZENG, Peng GAO, Peng XU, Yu CHENG, Jian LI, Jiaqiang CAI, Rudi BAO
  • Publication number: 20220267309
    Abstract: The present invention provides a mutant IDH inhibitor in dimeric or multimeric form. Specifically, the present invention provides a compound of formula I, Da-Wa-L-Wb-db??(I) or a pharmaceutically acceptable salt thereof. The compound of the present invention has excellent inhibitory activity against mutant IDH1.
    Type: Application
    Filed: April 9, 2020
    Publication date: August 25, 2022
    Applicant: EPITAS BIOSCIENCES (SHANGHAI) CO., LTD.
    Inventors: Mi ZENG, Haiping WU, Weixing ZHU
  • Patent number: 11214562
    Abstract: A compound of the Formula (1) is below provided where R1-R5 are as described in the description and each “*” represents a chiral center.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: January 4, 2022
    Assignee: ELI LILLY AND COMPANY
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Mi Zeng, Haizhen Zhang
  • Publication number: 20210292302
    Abstract: A compound of the Formula (1) is below provided where R1-R5 are as described in the description and each “*” represents a chiral center.
    Type: Application
    Filed: July 17, 2017
    Publication date: September 23, 2021
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Mi Zeng, Haizhen Zhang